🇺🇸 FDA
Patent

US 12318397

Methods and compositions for testosterone production

granted A61KA61K31/138A61K31/568

Quick answer

US patent 12318397 (Methods and compositions for testosterone production) held by Maximus Health, Inc. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Maximus Health, Inc.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/138, A61K31/568, A61K31/57, A61K31/573